Zobrazeno 1 - 9 of 9 pro vyhledávání: '"Pleural Neoplasms/pathology"'
1
BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma: A Validation Study
Autor: Amber Louw, Vasiliki Panou, Weronika Maria Szejniuk, Christos Meristoudis, Siaw Ming Chai, Chris van Vliet, Y. C. Gary Lee, Ian M. Dick, Tina Firth, Louise Andersen Lynggaard, Azadeh Birbaneh Asghari, Mogens Vyberg, Johnni Hansen, Jenette Creaney, Oluf Dimitri Røe
Publikováno v: Louw, A, Panou, V, Szejniuk, W M, Meristoudis, C, Chai, S M, van Vliet, C, Lee, Y C G, Dick, I M, Firth, T, Lynggaard, L A, Asghari, A B, Vyberg, M, Hansen, J, Creaney, J & Røe, O D 2022, ' BAP1 Loss by Immunohistochemistry Predicts Improved Survival to First-Line Platinum and Pemetrexed Chemotherapy for Patients With Pleural Mesothelioma : A validation study ', Journal of Thoracic Oncology, vol. 17, no. 7, pp. 921-930 . https://doi.org/10.1016/j.jtho.2022.04.008
INTRODUCTION: Pleural mesothelioma (PM) is an aggressive malignancy with no identified predictive biomarkers. We assessed whether tumor BAP1 status is a predictive biomarker for survival in patients receiving first-line combination platinum and pemet
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::56d4a12d531cfba9a0343a260fa2c6f6
https://doi.org/10.1016/j.jtho.2022.04.008
Zobrazit plný text záznamu
2
Expression of phosphorylated ribosomal protein S6 in mesothelioma patients - correlation with clinico-pathological characteristics and outcome: results from the European Thoracic Oncology Platform (ETOP) Mesoscape project
Autor: Jan Hendrik Rüschoff, Martina Haberecker, Zoi Tsourti, Kristiaan Nackaerts, Marc de Perrot, Luka Brcic, Ernest Nadal, Sotirios Tsimpoukis, Steven G. Gray, Luca Ampollini, Joachim G. Aerts, Emanuela Felley-Bosco, Michaela B. Kirschner, Kim Monkhorst, Birgit Weynand, Fatemeh Bavaghar-Zaeimi, Miroslav Samarzija, Roger Llatjos, Stephen P. Finn, Enrico Silini, Jan von der Thüsen, Nesa Marti, Karerina Vervita, Roswitha Kammler, Solange Peters, Rolf A. Stahel, Paul Baas, Isabelle Opitz, Rolf Stahel, Anita Hiltbrunner, Rosita Kammler, Patrick Vagenknecht, Barbara Ruepp, Urania Dafni, Panagiota Zygoura, Katerina Vervita, Georgia Dimopoulou, Charitini Andriakopoulou, Androniki Stavrou, Jan H. Rüschoff, Susanne Dettwiler, Fabiola Prutek, Christiane Mittmann, Bart Vrugt, Martina Friess, Alessandra Matter, Chloé Spichiger-Häusermann, Eric Verbeken, Birgit Weyenand, Liesbet Peeters, Marcello Tiseo, Enrico Maria Silini, Luigi Ventura, Letizia Gnetti, Paolo Carbognani, Fatemeh B. Zaeimi, Sven Seiwerth, Marko Jakopovic, Felipe Cardenal, Susana Lorente, Konstantinos Syrigos, Ioannis Vamvakaris, Paraskevi Boura, Steven Gray, Mutaz Mohammed Nur, Anne-Marie Baird, Martin Barr, Sinead Cuffe, Kathy Gately, Joachim Aerts
Publikováno v: Modern Pathology, 35(12), 1888-1899. SPRINGERNATURE
Modern Pathology, 35(12), 1888-1899. Nature Publishing Group
Pleural mesothelioma (PM) is an aggressive malignancy with poor prognosis. Although histology and pathologic stage are important prognostic factors, better prognostic biomarkers are needed. The ribosomal protein S6 is a downstream target of the phosp
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::355b5c339b724ea833e0f7b1c96df40e
https://doi.org/10.1038/s41379-022-01145-0
Zobrazit plný text záznamu
3
Response to 'Revisiting 'BAP1ness' in Malignant Pleural Mesothelioma'
Autor: Oluf Dimitri Røe, Jenette Creaney
Publikováno v: Røe, O D, Creaney, J & BAP1 Study Group 2022, ' Response to "Revisiting 'BAP1ness' in Malignant Pleural Mesothelioma" ', Journal of Thoracic Oncology, vol. 17, no. 8, pp. e69-e70 . https://doi.org/10.1016/j.jtho.2022.05.013
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e45d68980551b5decbdd050b3ae61409
https://pubmed.ncbi.nlm.nih.gov/35931424
Zobrazit plný text záznamu
4
Prophylactic radiotherapy for procedure tract metastases in mesothelioma
Autor: Arnold, David T, Clive, Amelia O
Publikováno v: Arnold, D T & Clive, A O 2017, ' Prophylactic radiotherapy for procedure tract metastases in mesothelioma ', Current Opinion in Pulmonary Medicine, vol. 23, no. 4, pp. 357-364 . https://doi.org/10.1097/MCP.0000000000000385
PURPOSE OF REVIEW: Malignant pleural mesothelioma is an aggressive malignancy with a very poor prognosis. The majority of patients require pleural procedures for diagnostic or fluid management purposes. Damage to the pleura during these procedures ca
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2642::5ecb0b2a2ec43d47ac6e440d24ac6127
https://research-information.bris.ac.uk/ws/files/198135777/Full_text_PDF_accepted_author_manuscript_.pdf
Zobrazit plný text záznamu
5
Positive pleural cytology is an indicator for visceral pleural invasion in metastatic pleural effusions
Autor: Dan Adler, Stavros Anevlavis, Elise Kaspi, Philippe Astoul, Georgia Karpathiou, Elisa Roca, Sophie Laroumagne, Hervé Dutau, Marios Froudarakis, Jérôme Pierre Olivier Plojoux
Publikováno v: CLINICAL RESPIRATORY JOURNAL
CLINICAL RESPIRATORY JOURNAL, 2018, 12 (3), pp.1011-1016. ⟨10.1111/crj.12619⟩
The Clinical Respiratory Journal, Vol. 12, No 3 (2018) pp. 1011-1016
International audience; IntroductionIn case of undiagnosed pleural effusions, it is necessary to conduct thoracentesis with pleural fluid (PF) cytology. Yet, sensitivity of PF cytology is widely variable as a result of sample size, experience, and pr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80e029ee105b61d86bb5291c91730e38
http://hdl.handle.net/11379/501126
Zobrazit plný text záznamu
7
Value of morphometry, texture analysis, densitometry and histometry in the differential diagnosis and prognosis of malignant mesothelioma
Autor: Paul Scheunders, W. Jacob, E. Van Marck, A. Van Daele, M. Koprowski, G. van de Wouwer, K. Dhaene, Barbara Weyn
Publikováno v: The journal of pathology
Malignant mesothelioma is a tumour with increasing incidence due to widespread use of its causative agent, asbestos, in the past decades. The poor survival necessitates a correct differentiation from other lesions at the same site, such as hyperplast
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::027b0bf37cc8c38c3be3de70a674b24f
https://lirias.kuleuven.be/handle/123456789/265478
Zobrazit plný text záznamu
8
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje